PELL Bio-Med Technology Co. Ltd. (6949.TW)

TWD 127.0

(8.09%)

Eps Summary of PELL Bio-Med Technology Co. Ltd.

  • PELL Bio-Med Technology Co. Ltd.'s latest annual eps in 2023 was -8.62 TWD , down -46.85% from previous year.
  • PELL Bio-Med Technology Co. Ltd.'s latest quarterly eps in 2024 Q1 was -1.56 TWD , up 17.46% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported an annual eps of -5.87 TWD in 2022, down -3.35% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported an annual eps of -5.68 TWD in 2021, down 0.0% from previous year.
  • PELL Bio-Med Technology Co. Ltd. reported a quarterly eps of -1.56 TWD for 2024 Q1, up 17.46% from previous quarter.
  • PELL Bio-Med Technology Co. Ltd. reported a quarterly eps of -2.49 TWD for 2023 Q3, up 9.45% from previous quarter.

Annual Eps Chart of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Created with Highcharts 11.1.0YearsEPS20212021.22021.42021.62021.820222022.22022.42022.62022.82023-9 TWD-8 TWD-7 TWD-6 TWD-5 TWD

Historical Annual Eps of PELL Bio-Med Technology Co. Ltd. (2023 - 2021)

Year Eps Eps Growth
2023 -8.62 TWD -46.85%
2022 -5.87 TWD -3.35%
2021 -5.68 TWD 0.0%

Peer Eps Comparison of PELL Bio-Med Technology Co. Ltd.

Name Eps Eps Difference
Apex Biotechnology Corp. 1.16 TWD 843.103%
Sinphar Pharmaceutical Co.,Ltd. 2.24 TWD 484.821%
Panion & Bf Biotech Inc. 0.90 TWD 1057.778%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 3.42 TWD 352.047%
GenMont Biotech Incorporation 0.38 TWD 2368.421%
Abnova (Taiwan) Corporation 0.72 TWD 1297.222%
Adimmune Corporation -1.52 TWD -467.105%
Tanvex BioPharma, Inc. -16.42 TWD 47.503%
Polaris Group -2.12 TWD -306.604%
Energenesis Biomedical CO.,LTD. -3.62 TWD -138.122%
UnicoCell Biomed Co., Ltd. -1.56 TWD -452.564%